• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的硬化剂泡沫制备自动化系统:对所产生的物理特性和所需设备设置的研究。

A new automated system for the preparation of sclerosant foam: A study of the physical characteristics produced and the device settings required.

机构信息

Vascular Surgery, 126700Hospital Universitari Sagrat Cor & General de Catalunya, Barcelona, Spain.

Vascular Surgery, Clínica Vascular Barcelona, Barcelona, Spain.

出版信息

Phlebology. 2020 Oct;35(9):724-733. doi: 10.1177/0268355520937615. Epub 2020 Jul 7.

DOI:10.1177/0268355520937615
PMID:32635818
Abstract

OBJECTIVES

To determine the quality of sclerosant foam produced with an automated preparation system with multiple combinations of sclerosing agents, gases, and device settings.

METHODS

Single-use mixing capsules filled with air or O/CO and polidocanol (0.25, 1, or 3%) or sodium tetradecyl sulfate (0.2 or 1%) were coupled to a customized magnetic stirrer. Stirring speed and time were adjusted between 1500 and 4000 r/min and 30 and 60 s, respectively, and characteristics of the foam produced were measured: half-life, bubble diameter, and gas-to-liquid ratio.

RESULTS

With optimized device settings, the following foam characteristics were obtained: half-life range, 1.4 ± 0.9 to 5.2 ± 0.6 min; bubble diameter, 84 ± 14 to 119 ± 6 µm; and gas-to-liquid ratio, 5:1-7:1. Sodium tetradecyl sulfate foam was quicker to form than polidocanol but faster to degrade. Foams with low sclerosant concentrations and O/CO required higher speed and longer time.

CONCLUSIONS

Suitable foam characteristics could be obtained with all combinations of sclerosing agent, concentration, and gas.

摘要

目的

确定使用具有多种硬化剂、气体和设备设置组合的自动化制备系统生产的硬化剂泡沫的质量。

方法

将装有空气或 O/CO 和聚多卡醇(0.25%、1%或 3%)或十四烷基硫酸钠(0.2%或 1%)的一次性混合胶囊与定制的磁力搅拌器相连。搅拌速度和时间分别调整为 1500 至 4000 r/min 和 30 至 60 s,并测量产生的泡沫特性:半衰期、气泡直径和气液比。

结果

通过优化设备设置,获得了以下泡沫特性:半衰期范围为 1.4±0.9 至 5.2±0.6 min;气泡直径为 84±14 至 119±6 µm;气液比为 5:1-7:1。十四烷基硫酸钠泡沫的形成速度快于聚多卡醇,但降解速度也更快。低浓度硬化剂和 O/CO 的泡沫需要更高的速度和更长的时间。

结论

可以使用硬化剂、浓度和气体的所有组合获得合适的泡沫特性。

相似文献

1
A new automated system for the preparation of sclerosant foam: A study of the physical characteristics produced and the device settings required.一种新型的硬化剂泡沫制备自动化系统:对所产生的物理特性和所需设备设置的研究。
Phlebology. 2020 Oct;35(9):724-733. doi: 10.1177/0268355520937615. Epub 2020 Jul 7.
2
Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.泡沫硬化疗法的新进展:聚焦于Varithena®(聚多卡醇静脉微泡沫)在静脉曲张治疗中的应用。
Phlebology. 2018 Apr;33(3):150-162. doi: 10.1177/0268355516687864. Epub 2017 Feb 6.
3
Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.基于组织学评估及临床相关性,评价十四烷基硫酸钠和聚多卡醇作为腿部毛细血管扩张硬化剂的效果。
Phlebology. 2017 Aug;32(7):496-500. doi: 10.1177/0268355516673768. Epub 2016 Oct 12.
4
Generation of sclerosant foams by mechanical methods increases the foam temperature.通过机械方法生成硬化剂泡沫会提高泡沫温度。
Phlebology. 2017 Aug;32(7):501-505. doi: 10.1177/0268355516671625. Epub 2016 Oct 12.
5
Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.硬化治疗中泡沫的稳定性:十四烷基硫酸钠与聚多卡醇之间的差异以及双注射器系统技术中使用的连接器类型
Dermatol Surg. 2005 Jan;31(1):19-22. doi: 10.1111/j.1524-4725.2005.31008.
6
Physiochemical properties and reproducibility of air-based sodium tetradecyl sulphate foam using the Tessari method.采用泰萨里方法制备的空气基十四烷基硫酸钠泡沫的物理化学性质及重现性。
Phlebology. 2017 Jul;32(6):390-396. doi: 10.1177/0268355516655078. Epub 2016 Jun 20.
7
Sclerotherapy: a study comparing polidocanol in foam and liquid form.硬化疗法:一项比较聚多卡醇泡沫剂和液体剂型的研究。
Phlebology. 2010 Feb;25(1):44-9. doi: 10.1258/phleb.2009.008064.
8
Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.聚多卡醇静脉微泡沫(Varithena®)与医生配制泡沫相比的益处。
Phlebology. 2016 May;31(4):283-95. doi: 10.1177/0268355515589063. Epub 2015 Jun 1.
9
A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.静脉曲张学中硬化泡沫稳定性的研究综述。
Dermatol Surg. 2020 Feb;46(2):249-257. doi: 10.1097/DSS.0000000000002039.
10
Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.聚多卡醇泡沫剂型与液体剂型在大隐静脉硬化治疗中的疗效评估:初步结果
Dermatol Surg. 2003 Dec;29(12):1170-5; discussion 1175. doi: 10.1111/j.1524-4725.2003.29398.x.

引用本文的文献

1
Preliminary Results of the First 50 Patients Undergoing Sclerotherapy for II-Degree Hemorrhoidal Disease Using an Automated Device.使用自动装置对50例二度痔病患者进行硬化治疗的初步结果
Front Surg. 2022 Apr 14;9:882030. doi: 10.3389/fsurg.2022.882030. eCollection 2022.